Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral Suppression.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 38703389.
- Also identified by DOI 10.1093/cid/ciae241 and PMC identifier 11426266.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case-control study explored cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatis B virus (HIV/HBV) coinfection with HIV viral suppression. Among patients taking tenofovir disoproxil fumarate, median TFV-DP levels in dried blood spots were ∼3-fold lower among patients with incomplete HBV viral suppression (n = 4) compared to those with complete suppression (n = 5) (516 vs 1456 fmol/punch).
Medical subject headings
- Tenofovir
- HIV Infections
- Coinfection
- Viral Load
- Hepatitis B